Endocrine Society GUIDELINES Bundle (free trial)

Treatment of Diabetes in Older Patients

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1140241

Contents of this Issue

Navigation

Page 12 of 17

13 Eye Complications ➤ In patients aged 65 years and older with diabetes, ES recommends annual comprehensive eye exams to detect retinal disease (1|⊕⊕⊕⊕). Technical Remark: Screening and treatment should be conducted by an ophthalmologist or optometrist in line with present-day standards. Neuropathy, Falls, and Lower Extremity Problems ➤ In patients aged 65 years and older with diabetes and advanced chronic sensorimotor distal polyneuropathy, ES suggests treatment regimens that minimize fall risk, such as the minimized use of sedative drugs or drugs that promote orthostatic hypotension and/or hypoglycemia. (2|⊕ ) ➤ In patients aged 65 years and older with diabetes and peripheral neuropathy with balance and gait problems, ES suggests referral to physical therapy or a fall management program to reduce the risk of fractures and fracture-related complications. (2|⊕ ) ➤ In patients aged 65 years and older with diabetes and peripheral neuropathy and/or peripheral vascular disease, ES suggests referral to a podiatrist, orthopedist or vascular specialist for preventive care to reduce the risk of foot ulceration and/or lower extremity amputation. (2|⊕⊕ ) Chronic Kidney Disease ➤ In patients aged 65 years and older with diabetes who are not on dialysis, ES recommends annual screening for CKD with an eGFR and urine albumin/creatinine ratio. (1|⊕⊕⊕⊕) ➤ In patients aged 65 years and older with diabetes who are in Group 3 (poor health) of the framework (see Table 3) and have a previous albumin/ creatinine ratio of <30 mg/g, ES suggests against additional annual albumin creatinine ratio measurements. (2|⊕⊕ ) ➤ In patients aged 65 years and older with diabetes and decreased eGFR, ES recommends limiting the use or dosage of many classes of diabetes medications to minimize the side effects and complications associated with CKD. (1|⊕⊕ ) Technical Remark: Specific use/dosing guidance on each class of diabetes medication is provided in Table 6.

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Treatment of Diabetes in Older Patients